Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: StayFine: Personalised Relapse Prevention of Anxiety and Mood Disorders in Youths [NA]

View source ↗

Summary

This entry provides the status of the StayFine study, a personalized relapse-prevention trial for anxiety and mood disorders in youths; the trial is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ggz Oost Brabant | Conditions: Depressive Disorder, Anxiety Disorders | NA | Status: ACTIVE_NOT_RECRUITING